Your browser doesn't support javascript.
loading
Acquired Tertiary MET Resistance (MET D1228N and a Novel LSM8-MET Fusion) to Selpercatinib and Capmatinib in a Patient With KIF5B-RET-positive NSCLC With Secondary MET Amplification as Initial Resistance to Selpercatinib.
Zhu, Viola W; Zhang, Shannon S; Zhang, Jian; Swensen, Jeffrey; Xiu, Joanne; Ou, Sai-Hong Ignatius.
Afiliação
  • Zhu VW; Department of Medicine, University of California Irvine School of Medicine, Orange, California; Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, California.
  • Zhang SS; Department of Medicine, University of California Irvine School of Medicine, Orange, California.
  • Zhang J; Caris Life Science Inc, Phoenix, Arizona.
  • Swensen J; Caris Life Science Inc, Phoenix, Arizona.
  • Xiu J; Caris Life Science Inc, Phoenix, Arizona.
  • Ou SI; Division of Hematology-Oncology, Department of Medicine, University of California Irvine School of Medicine, Orange, California; Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, California. Electronic address: siou@hs.uci.edu.
J Thorac Oncol ; 16(7): e51-e54, 2021 07.
Article em En | MEDLINE | ID: mdl-34154791
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2021 Tipo de documento: Article